Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2020-07-22
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in
patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month
treatment period with an 8-month extended follow-up.